AzTrials
AzTrials

Hoarding DisorderLOSSNCT03487224

Neural Mechanisms of Decision Making in Hoarding Disorder

An observational study of Hoarding Disorder, run by Stanford University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this study is to understand the neural mechanisms of decision making in hoarding disorder. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Hoarding Disorder
What is being tested?
MRI with fMRI frequency
Type of treatment
Medical device
How many people
25 participants
Where
1 siteUnited States
Study dates
8 Jul 2018to 30 May 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Individuals with Hoarding Disorder and Healthy Participants

Who may be able to join

  • ages 18-70
  • primary diagnosis of hoarding disorder
  • sufficient severity of hoarding symptoms
  • stable on psychotropic medications for 1 month prior to study enrollment
  • capacity to provide informed consent
  • ability to tolerate clinical study procedures
Show all 9Show fewer
  • ages 18-70
  • capacity to provide informed consent
  • Identify exclusion criteria.

Who cannot join

  • psychiatric or medical conditions that make participation unsafe
  • pregnant or nursing females
  • concurrent use of any medications that might increase the risk of participation (e.g. drug interactions)
  • presence of metallic device or dental braces
  • any current or lifetime psychiatric diagnosis
  • current or past use of psychotropic medication
Show all 9Show fewer
  • pregnant or nursing females
  • major medical or neurological problem
  • presence of metallic device or dental braces

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stanford University

    Stanford, California, 94305

Other trials in United States

About this study

The purpose of this study is to understand the neural mechanisms of decision making in hoarding disorder.

Read the detailed description

Hoarding disorder is a common and disabling disorder that represents a significant public health problem. This study aims to build on current research on decision making by examining these processes in hoarding disorder.

Being tested
MRI with fMRI frequency
Keywords
Hoarding Disorder
Medical subject headings
Hoarding Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRI with fMRI frequencyDevice

    Functional magnetic resonance imaging or fMRI measures brain activity by detecting changes in blood flow. Participants will do cognitive tasks during fMRI.

Study groups in NCT03487224
Study groupRoleWhat they receive
Hoarding DisorderAdults diagnosed with Hoarding Disorder
Receives: Device: MRI with fMRI frequency
Healthy ControlsAdults without mental illness
Receives: Device: MRI with fMRI frequency

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. BOLD signal

    BOLD signal derived from fMRI

    Measured: up to 90 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2018
  2. Study start8 Jul 2018
  3. Primary completion30 May 2027 (estimated)
  4. Study completion30 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03487224
Sponsor's protocol ID
42327
Acronym
LOSS
Status last verified
Aug 2026
First submitted
27 Mar 2018
Last updated
13 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hoarding Disorder, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

BOLD signal (time frame: up to 90 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in